Published in Br J Dermatol on February 01, 2001
Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol (2013) 3.32
Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev (2014) 1.38
An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains. PLoS One (2012) 1.34
Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrob Agents Chemother (2002) 1.27
Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori. Antimicrob Agents Chemother (2008) 1.08
Genotypic and antimicrobial characterisation of Propionibacterium acnes isolates from surgically excised lumbar disc herniations. Biomed Res Int (2013) 1.08
Cross-sectional Pilot Study of Antibiotic Resistance in Propionibacterium Acnes Strains in Indian Acne Patients Using 16S-RNA Polymerase Chain Reaction: A Comparison Among Treatment Modalities Including Antibiotics, Benzoyl Peroxide, and Isotretinoin. Indian J Dermatol (2016) 1.03
Antibiotics in acne: time for a rethink. Br J Dermatol (2001) 0.97
Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic. Antimicrob Agents Chemother (2007) 0.92
Bacterial resistance to antibiotics in acne vulgaris: an in vitro study. Indian J Dermatol (2008) 0.90
Acne: more than skin deep. Postgrad Med J (2006) 0.90
In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes. J Clin Aesthet Dermatol (2011) 0.85
Which is the best treatment for prosthetic joint infections due to Propionibacterium acnes: need for further biofilm in vitro and experimental foreign-body in vivo studies? Acta Orthop (2016) 0.83
Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. J Clin Aesthet Dermatol (2011) 0.79
The Formulation of Bacteriophage in a Semi Solid Preparation for Control of Propionibacterium acnes Growth. PLoS One (2016) 0.77
Susceptibility of Propionibacterium acnes isolated from patients with acne vulgaris to zinc ascorbate and antibiotics. Clin Cosmet Investig Dermatol (2011) 0.76
A Derivative of the Thiopeptide GE2270A Highly Selective against Propionibacterium acnes. Antimicrob Agents Chemother (2015) 0.76
Efficacy of mupirocin and rifampin used with standard treatment in the management of acne vulgaris. Iran J Pharm Res (2013) 0.75
Chronic administration of oral trimethoprim-sulfamethoxazole for acne vulgaris. J Clin Aesthet Dermatol (2011) 0.75
Activity of the novel macrolide BAL19403 against ribosomes from erythromycin-resistant Propionibacterium acnes. Antimicrob Agents Chemother (2007) 0.75
Non-antibiotic Isotretinoin Treatment Differentially Controls Propionibacterium acnes on Skin of Acne Patients. Front Microbiol (2017) 0.75
Invasive Propionibacterium acnes infections in a non-selective patient cohort: clinical manifestations, management and outcome. Eur J Clin Microbiol Infect Dis (2014) 0.75
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet (1999) 5.36
Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol Microbiol (1990) 4.03
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer (1999) 3.19
Vitiligo, thyroid disease and autoimmunity. Br J Dermatol (1968) 3.18
Pseudomonas aeruginosa: a formidable and ever-present adversary. J Hosp Infect (2009) 3.06
Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol (1998) 3.02
Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin. J Am Acad Dermatol (2001) 2.80
The rate of sebum excretion in man. Br J Dermatol (1969) 2.68
Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. J Antimicrob Chemother (1989) 2.62
Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol (1974) 2.43
Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol (2002) 2.34
Evaluation of the modified Alvarado score in the diagnosis of acute appendicitis: a prospective study. Ann R Coll Surg Engl (1994) 2.32
Treatment of Behcet's syndrome with phenformin and ethyloestrenol. Lancet (1969) 2.28
Evaluation of a policy of total mesorectal excision for rectal and rectosigmoid cancers. Br J Surg (1997) 2.26
Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J Antimicrob Chemother (1993) 2.25
Antibiotic-resistant acne: lessons from Europe. Br J Dermatol (2003) 2.22
Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin Cancer Res (1999) 2.20
Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France. J Clin Microbiol (2000) 2.18
Screening for breast cancer detects tumours at an earlier biological stage. Br J Surg (1993) 2.16
Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampC. J Antimicrob Chemother (2000) 2.15
Pathogenesis of acne. Lancet (1969) 2.10
Community-acquired meticillin-resistant Staphylococcus aureus in Australia. Australian Group on Antimicrobial Resistance. Lancet (1998) 2.08
Chromosomally encoded cephalosporin-hydrolyzing beta-lactamase of Proteus vulgaris RO104 belongs to Ambler's class A. Biochim Biophys Acta (1994) 2.07
Suicide in dermatological patients. Br J Dermatol (1997) 2.07
A variety of gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother (1999) 2.04
Regional variations of cutaneous propionibacteria. Appl Environ Microbiol (1978) 2.00
Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production. FEMS Microbiol Lett (1999) 1.97
16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob Agents Chemother (1998) 1.94
Post-adolescent acne: a review of clinical features. Br J Dermatol (1997) 1.94
A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol (1994) 1.88
The microbiology of the human axilla and its relationship to axillary odor. J Invest Dermatol (1981) 1.82
Analyses of volatile organic compounds from human skin. Br J Dermatol (2008) 1.82
Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. BMJ (1989) 1.73
The prevalence of acne vulgaris in adolescence. Br J Dermatol (1971) 1.72
Roaccutane treatment guidelines: results of an international survey. Dermatology (1997) 1.70
Incidence of synchronous and metachronous colorectal carcinoma. Br J Surg (1984) 1.68
Characterization and amino acid sequence analysis of a new oxyimino cephalosporin-hydrolyzing class A beta-lactamase from Serratia fonticola CUV. Biochim Biophys Acta (1997) 1.67
Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol (1983) 1.67
Topical tretinoin for photoaged skin. J Am Acad Dermatol (1986) 1.67
Rectal retroflexion: an essential part of lower gastrointestinal endoscopic examination. Dis Colon Rectum (2001) 1.67
Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol (1989) 1.65
Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J (1979) 1.64
Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob Agents Chemother (1997) 1.63
Photoaging/photodamage and photoprotection. J Am Acad Dermatol (1990) 1.63
Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients. Br J Dermatol (1990) 1.61
Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res (1990) 1.61
Identification of a chromosomally encoded ABC-transport system with which the staphylococcal erythromycin exporter MsrA may interact. Gene (1995) 1.57
Human health consequences of use of antimicrobial agents in aquaculture. Clin Infect Dis (2009) 1.54
Physiologic, microbiologic, and seasonal effects of handwashing on the skin of health care personnel. Am J Infect Control (1986) 1.51
Genetic control of sebum excretion and acne--a twin study. Br J Dermatol (1988) 1.47
The pathological and biological nature of screen-detected breast carcinomas: a morphological and immunohistochemical study. J Pathol (1997) 1.47
Interaction of fluconazole with cyclosporin. Lancet (1989) 1.46
Colonisation with Escherichia coli resistant to "critically important" antibiotics: a high risk for international travellers. Eur J Clin Microbiol Infect Dis (2010) 1.46
Interactions between the oral contraceptive pill and antibiotics. Br J Dermatol (1990) 1.45
Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin. Dermatology (2006) 1.44
Influence of relative humidity and suspending menstrua on survival of Acinetobacter spp. on dry surfaces. J Clin Microbiol (1996) 1.43
Allergenic identity between the common floor mite (Dermatophagoides farinae Hughes, 1961) and house dust as a causative antigen in bronchial asthma. J Allergy (1968) 1.43
Prevalence of facial acne in adults. J Am Acad Dermatol (1999) 1.42
Alopecia areata treated with diphencyprone: is an allergic response necessary? Br J Dermatol (1990) 1.42
Description of Leeds Acinetobacter Medium, a new selective and differential medium for isolation of clinically important Acinetobacter spp., and comparison with Herellea agar and Holton's agar. J Clin Microbiol (1994) 1.42
Age-related changes in the resident bacterial flora of the human face. J Invest Dermatol (1975) 1.41
Sequence family variant loss from the AZFc interval of the human Y chromosome, but not gene copy loss, is strongly associated with male infertility. J Med Genet (2004) 1.40
The effect of 3-week tamoxifen treatment on oestrogen receptor levels in primary breast tumours: a flow cytometric study. Br J Cancer (1998) 1.40
Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol (1996) 1.40
The inter-relationship between isotretinoin/acne and depression. J Eur Acad Dermatol Venereol (1999) 1.40
ANCA associated vasculitis allergica cutis (VAC) and mild proliferative necrotizing glomerulonephritis. Clin Nephrol (1993) 1.40
Fabrication and reorganization of dermal equivalents suitable for skin grafting after major cutaneous injury. Biomaterials (1990) 1.40
Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol (1989) 1.40
European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol (2012) 1.40
[Treatment of seborrheic dermatitis]. Ann Dermatol Venereol (2004) 1.39
Asymptomatic acute poststreptococcal glomerulonephritis following upper respiratory tract infections caused by Group A streptococci. Clin Nephrol (1996) 1.39
Streptococcus faecalis arthritis. J Rheumatol (1989) 1.39
Acne fulminans: investigation of acute febrile ulcerative acne. Arch Dermatol (1977) 1.39
The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect (2012) 1.39
Acne vulgaris and malignancy. Br J Dermatol (1988) 1.38
Adverse effects of fluorinated steroids applied to the face. JAMA (1974) 1.38
Pathogenic JK group corynebacteria and their similarity to human cutaneous lipophilic diphtheroids. J Infect Dis (1985) 1.38
Hemodynamic study of hypotension during hemodialysis. Kidney Int (1982) 1.38
Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun (1995) 1.37
Safety of long-term high-dose minocycline in the treatment of acne. Br J Dermatol (1996) 1.35
Bacteriology. J Invest Dermatol (1976) 1.35
Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol (1975) 1.35